Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Laser treatment is safe and can effectively treat toenail fungus, especially when combined with other treatments if no improvement is seen after about a year.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Young rats are better for testing hair loss treatments after chemotherapy.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Trichoscopy is a useful tool for diagnosing hair and scalp issues, but doctors must be careful to avoid mistakes.

Hair loss requires customized treatments based on its various causes and types.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

The model and estimator can predict drug exposure in kidney transplant patients well.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.